Liver specialist Amit Singal joining Curve Biosciences  

BioCentury’s latest round of management updates for the biopharma sector includes the addition of Amit Singal to the team at San Mateo, Calif.-based Curve Biosciences Inc. Singal, who becomes CMO of the biotech, is chief of hepatology at UT Southwestern Medical Center and was the lead author of the most recent American Association for the Study of Liver Diseases Practice Guidance related to liver cirrhosis monitoring and management. Curve is using its Whole-Body Intelligence technology to monitor chronic diseases.

Alloy Therapeutics Inc. and DCx Biotherapeutics Corp. were among other biotechs adding to the C-suite. Alloy hired Alexander Titus as CEO, vigilance, to head its new vigilance unit focused on biosecurity and rapid therapeutic response. Titus is a commissioner on the U.S. National Security Commission on Emerging Biotechnology and was the first biotechnology strategy lead at the U.S. Department of Defense...